Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer

NCT01394120 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Pancreatic Ductal

Interventions

DRUG: Targeted Therapy Tailored Treatment
DRUG: Standard Chemotherapy

Sponsor

Sofia Perea, Director Clinical Trials Unit.